Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → ATF2 |
| (<<) ADCY7 → ATF2 |
| (<<) CREB1 → ATF2 |
| (<<) CSGALNACT2 → ATF2 |
| (<<) GNG10 → ATF2 |
| (<<) MAN2A2 → ATF2 |
| (<<) MTMR6 → ATF2 |
| (<<) SMAD5 → ATF2 |
| (<<) SMO → ATF2 |
| (<<) SOCS5 → ATF2 |
| (<<) SP3 → ATF2 |
| (<<) STAM2 → ATF2 |
| (<<) VCP → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → ADAM19 (>>) |
| ATF2 → ADCY3 (>>) |
| ATF2 → ARAF (>>) |
| ATF2 → ARSJ (>>) |
| ATF2 → CD4 (>>) |
| ATF2 → CDH22 (>>) |
| ATF2 → CEP170 (>>) |
| ATF2 → E2F4 (>>) |
| ATF2 → ELF3 (>>) |
| ATF2 → GNAI2 (>>) |
| ATF2 → GRIN2D (>>) |
| ATF2 → GYPC (>>) |
| ATF2 → HS3ST1 (>>) |
| ATF2 → IMPA1 (>>) |
| ATF2 → ITGA3 (>>) |
| ATF2 → ITGB5 (>>) |
| ATF2 → JAK3 (>>) |
| ATF2 → KLK5 (>>) |
| ATF2 → KRAS (>>) |
| ATF2 → MT1G (>>) |
| ATF2 → NFATC4 (>>) |
| ATF2 → NFKBIA (>>) |
| ATF2 → NOTCH2 (>>) |
| ATF2 → NR3C1 (>>) |
| ATF2 → PIK3CG (>>) |
| ATF2 → PLA2G12A (>>) |
| ATF2 → PPP1R3D (>>) |
| ATF2 → RAP1A (>>) |
| ATF2 → RCBTB1 (>>) |
| ATF2 → RNF11 (>>) |
| ATF2 → SCARB1 (>>) |
| ATF2 → SEH1L (>>) |
| ATF2 → SH3TC1 (>>) |
| ATF2 → SMAD2 (>>) |
| ATF2 → TNFRSF1A (>>) |
| ATF2 → TOP2B (>>) |
| ATF2 → UBE2L6 (>>) |
| ATF2 → VEGFB (>>) |
| ATF2 → WBP4 (>>) |
